 N- fluoroacetyl-D-glucosamine potential agent cancer diagnosis Positron substrates sugars amino acids nucleosides in-vivo evaluation biochemical processes cancerous tissue Hexosamines obligatory structural components many important macromolecules membrane glycoproteins mucopolysaccharide new synthesized pharmaceutical N- fluoroacetyl-D-glucosamine structural analog N-acetyl-D-glucosamine mice spontaneous hepatomas tissue distribution study min injection high uptakes tumor mean value dose/g kidney tumor uptake value tissue PET study carcinoma rabbit preliminary results potential new agent tumor imaging